Abstract
The choice of drugs in antineoplastic chemotherapy remains still largely empirical. A better understanding of some basic phenomena such as metabolism and kinetics of malignant cells is essential for a more rational choice and more efficient routes and schedules of anticancerous drug administration. Equally important, particularly for brain tumours, are pharmacological factors: the passage of drugs across the blood-brain barrier, their liposolubility, state of ionization, diffusion from cerebrospinal fluid (CSF) into the tumours, and their half-life in various compartments of the body.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ariel, I. M., 1961: Intra-arterial chemotherapy for metastatic cancer to the brain. Amer. J. Surg. 102, 647–650.
Aronson, H. A., Flanigan, S., Mark, J. B. D., 1963: Chemotherapy of malignant brain tumors using regional perfusion. I. Technic and patient selection. Ann. Surg. 157, 394–399.
Ausman, J. I., Shapiro, W. R., Rall, D. P., 1970: Studies on the chemotherapy of experimental brain tumors: Development G experimental model. Cancer Res. 30, 2394–2400.
Ausman, J. I., Levin, V. A., Brown, W. E., Rall, D. P., Fenstermacher, J. D., 1977: Brain-tumor chemotherapy. Pharmacological principles derived from a monkey brain-tumor model. J. Neurosurg. 46, 155–164.
Band, P. R., Weir, B. K. A., Urtasun, R. C., Blain, G., McLeon, D., Wilson, F., Mielke, B., Grace, M., 1974: Radiotherapy and CCNU in grade III and IV astrocytoma. ASCO abstracts 25, 161.
Barker, M., Hoshino, T., Gurcay, O., Wilson, C. B., Nielsen, S. L., Downie, R., Eliason, J., 1973: Development of an animal brain tumor. Model and its response to therapy with 1,3-BIS(2-Chloroethyl)-1-introsourea. Cancer Res. 33,976–986.
Bellman, S., Hugosson, R., Johansson, B., Sjögren, S. E., 1964: Chemotherapy of five supratentorial malignant gliomas with intra-arterial infusion of methotrexate. Acta Chir. Scand. 127,569–574.
Bleyer, W. A., Drake, J. C., Chabner, B. A., 1973: Neurotoxicity and elevated cerebrospinal fluid methotrexate concentration in meningeal leukemia. IV. Engl. J. Med. 289, 770–773.
Brihaye, J., Gueuning, Ch., Huysman, E., 1971: Les tumeurs cérébrales. In: chimiothérapie et chirurgie. Acta Chir. Belg., suppl. 1, 42–59.
Brisman, R., Houseplan, E. M., Chang, C., Duffy, P., Balis, E., 1976: Adjuvant nitrosourea therapy for glioblastoma. Arch. Neurol. 33, 745–750.
Brouty-Boye, G., Constans, J. P., 1976: Action comparative in vitro de divers agents antimitotiques sur des lignées cellulaires établies à partir de tumeurs cérébrales humaines. Neurochirurgie 22,69–76.
Burgess, E. A., Sylven, D., 1962: Glucose, lactate and lactic dehydrogenase activity in normal interstitial fluid and that of mouse tumours. Cancer Res. 22,581–587.
Chassard, J. L., Dutou, L., Gerard, J. P., Papillon, J., 1975: La radiothérapie postopératoire des gliomes hémisphériques de l’adulte. A propos d’une statistique de 134 observations. Neurochirurgie 21,377–390.
Chen, T. T., Meahey, J., Jr., 1973: Effect of corticosteroid on protein and nucleic acid synthetics in human glial tumor cells. Cancer Res. 33, 1721–1723.
Cuatico, W., Cho, J. R., Spiegelman, S., 1973: Particles with RNA of high molecular weight and RNA-directed DNA polymerose in human brain tumors. Puec. Nat. Acad. Sci. 70,2789–2793.
Davis, P. L., Shumway, M. H., Siu, B., 1958: Triethylenethiophosphoramide in treatment of metastatic cerebral malignancy. JAMA 167, 726–727.
Davis, P. L., Shumway, M. H., 1961: Thiotepa in treatment of metastatic cerebral malignancy. JAMA 175, 714–715.
Denlinger, R. H., Koestner, A., Swenberg, J. A., 1973: An experimental model for selective production of neoplasms of the peripheral nervous system. Acta Neuropathol. 23, 219–229.
Eckman, W. W., Patlak, C. S., Fenstermacher, J. D., 1974: A critical evaluation of the principles governing the advantages of intra-arterial infusions. J. Pharmacokinet. Biopharm. 2, 257–285.
Edland, R. W., Javid, M., Ansfield, F. J., 1971: Glioblastoma multiforme. An analysis of the results of post operative radiotherapy alone versus radiotherapy and concomitant s’fluorouracil. Amer. J. Roentg. 3, 337–342.
Engelhardt, P., 1976: Intrathecal cystostatic therapy of meningeal carcinomatosis. Autoradiographie investigations of the CSF cells. J. Neurol. 213, 309–315.
EORTC Brain Tumor Group, 1976: Effect of CCNU on survival, rate of objective remission and duration of free interval in patients in the malignant brain gliomafirst evaluation. Eur. J. Cancer 12,41–45.
Fewer, D., Wilson, C. B., Boldrey, E. B., Enot, J. K., 1972: Phase II study of CCNUNSC 79037 in the treatment of brain tumours. Cancer Chemother. Rep. 56, 421–427.
Fewer, D., Powell, M. R., 1972: The chemotherapy of brain tumours. Clinical experience in the carmustine (BCNU) and vincristine. JAMA 222, 549–552.
Frankel, S. A., German, W. J., 1958: Glioblastoma multiforme. Review of 219 cases with regard to natural history, pathology, diagnostic methods and treatment. J. Neurosurg. 15,489–503.
French, J. D., West, P. M., Amerongen, F. K. von, Magoun, H. W., 1952: Effects of intracarotid administration of nitrogen mustard on normal brain and brain tumors. J. Neurosurg. 9, 378–389.
Fumagalli, R., Grossi-Paoletti, E., Paoletti, P., Paoletti, R., 1964: Studies on lipids in brain donors. I occurence and signification of sterol precursors of cholesterol in human brain tumors. J. Neurosurg. 2, 561–565.
Garfield, J., Dayan, A. D., 1973: Postoperative intracavity chemotherapy of malignant gliomas. A preliminary study using methotrexate. J. Neurosurg. 39, 315–322.
Garfield, J., Dayan, A. D., Weller, R. O., 1975: Postoperative intracavity chemotherapy of malignant supratentorial astrocytomas using BCNU. Clinical Oncology 1, 213–222.
Geran, R. I., Congleton, G. F., Dudeck, L. E., Abbott, B. J. de, Gargus, J. L., 1974: A mouse ependymoblastoma as an experimental model for screening potential antimoplastic drugs. Cancer Chemother. Rep. 4, 53–87.
Grasso, R. J., 1976: Transient inhibition of cell proliferation by glucocorticoids in rat glioma monolayer cultures. Abstracts Am. Ass. Cancer Res., p. 82.
Greenhouse, A. H., Neubuerger, K. T., Bowerman, D. L., 1964: Brain damage after intracarotid infusion of methotrexate. Arch. Neurol. 11, 618–625.
Gurcay, O., Wilson, C. B., Barker, M., Eliason, J., 1971: Corticoid effects on transplantable rat glioma. Arch. Neurol. 24, 266–269.
Gutin, Ph., Weiss, H. D., Wiernik, P. H., Walker, M. D., 1976: Intrathecal N, N’, N“-Triethylenethiophosphamide [Thio-Tepa (NSC 6396)] in the treatment of malignant meningeal disease. Phase I-CII study. Cancer 38, 1471–1475.
Hayakawa, T., Yamada, R., Kanai, N., Kuroda, R., Ushio, Y., Higashi, H., Mogami, H., 1970: Intrathecal chemotherapy. Selection of cytostatic agents. Brit. J. Cancer 24, 489–497.
Hayakawa, T., Ushio, Y., Morimoto, K., Hasegawa, H., Mogami, H., Horibata, K., 1976: Uptake of bleomycin by human brain tumours. J. Neurol. Neurosurg. Psych. 39, 341–349.
Heppner, F., Diemath, H. E., 1963: Lokale Chemotherapie der Hirntumoren. Acta Neurochir. (Wien) 11, 287–293.
Hildebrand, J., Levin, S., 1973: Enzymatic activities in cerebrospinal fluid in patients with neurological diseases. Acta Neurol. Belg. 73, 229–240.
Hildebrand, J., Brihaye, J., Wagenknecht, L., Michel, J., Kenis, Y., 1975: Combination therapy with CCNU, vincristine and methotrexate in primary and metastatic brain tumors. Eur. J. Cancer 11, 585–587.
Hoshino, T., Barker, M., Wilson, C. B., Boldrey, E. B., Fewer, D., 1972: Cell kinetics of human gliomas. J. Neurosurg. 37, 15–26.
Hoshino, T., Barker, M., Wilson, C. B., 1975: The kinetics of cultured human glioma cells. Acta Neuropathol. 32, 235–244.
Hoshino, T., Wilson, C. B., Rosenblum, M. L., Barker, M., 1975: Chemotherapeutic implications of growth fraction and cell cycle time in glioblastomas. J. Neurosurg. 43, 127–135.
Introzzi, G., Paoletti, P., Pezzotta, S., Robustelli della Cuna, G., Rodriguezy Baena, R., 1975: The use of BCNLT in chemotherapy of tumors of the central nervous system. J. Neurosurg. Sei. 19, 223–225.
Jelsma, R., Bucy, P. C., 1967: The treatment of glioblastoma multiforme of the brain. J. Neurosurg. 27, 388–400.
Jelsma, R., Bucy, P. C., 1969: Glioblastoma multiforme. Its treatment and some factors. Effecting survival. Arch. Neurol. 20, 161–171.
Kennedy, B. J., Brown, J. H., Yarbo, J. W., 1965: Mithramycin (NSC-24559) therapy for primary glioblastomas. Cancer Chemother. Rep. 48, 59–63.
Kennedy, B. J., Yarbo, J. W., Kickertz, V., Sandberg-Wollheim, M., 1968: Effects of mithramycin on a mouse glioma. Cancer Res. 28, 91–97.
Khanna, H. L., Bailey, I. C., Taylor, A. R., Grebbell, F. S., 1969: Epodyl in the management of cerebral glioma. Neurology 19, 570–573.
Koestner, A., Swenberg, J. A., Wechsler, W., 1972: Experimental tumors of the nervous system induced by resorptive N-nitrosourea compounds. In: Progress in Experimental Tumor Research 17, 9–30. Editor G. Bingham Basel: S. Karger.
Kontras, S. B., Newton, W. A., Sayers, M. P., 1962: Preliminary report on the use of intrathecal methotrexate in brain tumors of childhood. Proc. Amer. Ass. Cancer Res. 3, 151.
Koo, A. H., Fewer, D., Wilson, C. B., Newton, T. H., 1972: Lack of correlation between clinical and angiographie findings in patients with brain tumours under BCNU chemotherapy. J. Neurosurg. 37, 9–14.
Kumar, A. R. V., Renaudin, J., Wilson, C. B., Boldrey, E. B., Enot, K. J., Levin, V. A., 1974: Procarbazine hydrochloride in the treatment of brain tumors. Phase 2 study. J. Neurosurg. 40,365–371.
Kun-Yu Wu, K., Jacobsen, C. D., Hoak, J. C., 1973: Plasminogen in normal and abnormal human cerebrospinal fluid. Arch. Neurol. 28, 64–66.
Lassman, L. P., Pearce, G. W., Gang, J., 1965: Sensitivity of intracranial gliomas to vincristine sulphate. Lancet, no. 7380, 296–297.
Laurent, G., Atassi, G., Hildebrand, J., 1976: Potentiation of 1-(2-chloroethyl)3-cyclohexyl-1-nitrosourea (CCNU) by amphoterican B (AMB) in marine ependymoblastoma. Cancer Res. 36, 4069–4073.
Levin, V. A., Shapiro, W. R., Clancy, T. P., Oliverio, V. T., 1970: The uptake, distribution, and antitumor activity of 1-(2-chloroethyl)-3-cyclohexyl-3-nitrosourea in the murin glioma. Cancer Res. 30,2451–2455.
Levin, V. A., Kabra, P., 1975: Brain and tumor pharmacokinetics of BCNU and CCNU following I.V. and intracarotid artery (I.C.A.) administration. Proc. Amer. Ass. Cancer Res. 16,19.
Levine, M. A., Walker, M. D., Weiss, H. D., 1974: Intravenous methyl-CCNU in the treatment of malignant glioma. ASCO Abstracts, p. 167.
Long, J. M., 1970: Capillary ultrastructure and the blood-brain barrier in human malignant brain tumors. J. Neurosurg. 32,127–144.
Luyendijk, W., Beusekom, G. Th. van, 1966: Chemotherapy of cerebral gliomas with intracarotid methotrexate-infusion. Acta Neurochir. (Wien) 15,234–248.
Matricali, B., 1974: Chemotherapie van het maligne gliomaa cerebri. Nederland. Tijdschr. Geneesk. (in press).
Maker, H. S., Lehrer, G. M., Silides, D. J., Weiss, C., 1969: Circulatory factors in the carbohydrate metabolism of an experimental glial neoplasm. Ann. N.Y. Acad. Sei. 195,461–471.
Marne, L., Nouet, J. P., Robert, J., Chai, N., Houdart, R., 1973: Use of radioactive bleomycin to detect malignant intracranial tumors. J. Neurosurg. 39,735–741.
Mark, V. H., Kjellberg, R. N., Ojemann, R. G., Soloway, A. H., 1960: Treatment of malignant brain tumors with alkylating agents. (Thiotepa triethylene thiophosphoramide): Its differential concentration and toxicity after arterial infusion. Neurology 10, 772–776.
Mathe, G., Kenis, Y., 1975: La chimiothérapie des cancers. Paris: Expansion scientifique française. 1975.
Morton, L. J., Heby, O., Levin, V. A., Lubich, W. P., Crafts, D. C., Wilson, C. B., 1976: The relationship of polyamines in cerebrospinal fluid to the presence of central nervous system tumors. Cancer Res. 36, 973–977.
Newton, K. A., 1962: Intermittent intra-arterial injection and continuous intravenous infusion in the treatment of advanced cancer. Proc. Roy. Soc. Med. 55, 646–649.
Newton, W. A., Jr., Sayers, H. P., 1965: Intrathecal methotrexate therapy of brain tumors of childhood. Proc. Amer. Ass. Cancer Res. 4,190.
Newton, W. A., Sayers, M. P., Samuels, L. D., 1968: Intrathecal methotrexate therapy NSC-740 for brain tumors in children. Cancer Chemother. Rep. 52, 257–261.
Norrel, H., Wilson, C. B., 1967: Brain tumor chemotherapy with methotrexate given intrathecally. JAMA 201, 93–95.
Ommaya, A. K., Rubin, R. C., Henderson, E. S., Rall, D. P., Gieseke, F. G., Bering, E. A., Bagan, M., 1965: A new approach to the treatment of inoperable brain tumors. Med. Ann. DC. 34, 455–458.
Perese, D. M., Day, C. E., Chardack, W. M., 1962: Chemotherapy of brain tumors by intra-arterial infusion. J. Neurosurg. 19, 215–219.
Pons, A., Armand, J. P., Combes, P. F., Nadal, P., 1975: Survie des malades atteints de tumeurs cérébrales sus-tentorielle primitives, en fonction des associations thérapeutiques. Neurochirurgie 21,408–410.
Price, L. A., Goldie, J. H., Hill, B. T., 1975: Methodichlorophen as anti-tumor drug. Brit. Med. J. 2, 20–21.
Pouillart, P., Schwarzenberg, L., Ameil, J. L., Mathe, G., Huguenin, P., Morin, P., Baron, A., Laparre, Ch., Parrot, R., 1975: Combinaisons chimiothérapiques de drogues se potentialisant. III. Application aux tumeurs primitives du système nerveux central. Nouv. Presse Méd. 4, 713–721.
Ransohoff, J., Martin, B. F., Medrek, T. J., Harris, M. N., Golomb, F. M., Wright, J. C., 1965: Preliminary clinical study of mithramycin (NSC-24559) in primary tumors of the central nervous system. Cancer Chemother. Rep. 49,51–57.
Reagan, T. J., Bisel, H. F., Childs, D. S., Layton, D. D., Rhoton, A. L., Taylor, W. F., 1976: Controlled study of CCNU and radiation therapy in malignant astrocytoma. J. Neurosurg. 44, 186–190.
Renaudin, J., Fewer, D., Wilson, C. B., Boldrey, E. B., Calogero, J., Enot, K. J., 1973: Dose dependency of Decadron in patients with partially excised brain tumors. J. Neurosurg. 39,302–305.
Rieselbach, R. E., Dichiro, G., Freireich, E. J., Rail, D. P., 1962: Subarachnoid distribution of drugs after lumbar injection. New Engl. J. Med. 267,1273–1278.
Ringkjeb, R., 1968: Treatment of intracranial gliomas and metastatic carcinomas by local application of cytostatic agents. Acta Neurol. Scand. 44, 318–322.
Rosen, J. M., Rosen, F., Milholland, R. J., Nichol, C. H., 1970: Effects of cortisol on DNA metabolism in the sensitive and resistant lines of mouse lymphoma. Cancer Res. 30,1129–1136.
Rosenblum, M. L., Bowie, D. L., Walker, M. D., 1973: Diffusion in vitro and in vivo of 1- (2-chloroethyl)-3- (trans-4-methylcyclohexyl)-1-introsourea from silicone rubber capsules, a potentially new mode of chemotherapy administration. Cancer Res. 33, 906–914.
Rosenblum, M. L., Reynolds, A. F., Smith, K. A., Rumach, B. H., Walker, M. D., 1973: Chloroethylcycloethyl-introsourea (CCNU) in the treatment of malignant brain tumours. J. Neurosurg. 39, 306–314.
Rosenblum, M. L., Wheeler, K. T., Wilson, C. B., Barker, M., Knebel, K. D., 1975: In vitro evaluation of in vivo Brain tumor chemotherapy with 1,3-BIS- (2-chloroethyl)-1-introsourea. Cancer Res. 35, 1387–1391.
Rosenblum, M. L., Knebel, K. D., Vasquez, D. A., Wilson, C. B., 1977: Brain-tumor therapy. Quantitative analysis using a model system. J. Neurosurg. 46,145–154.
Rosenstock, J. G., Evans, A. E., Schut, L., 1976: Response to vincristine of recurrent brain tumors in children. J. Neurosurg. 45, 135–140.
Roth, J. G., Elvidge, A. R., 1960: Glioblastoma multiforme: a clinical survey. J. Neurosurg. 172,736–750.
Rubin, R. C., Ommaya, A. K., Henderson, E. S., Bering, E. A., Rall, D. P., 1966: Cerebrospinal fluid perfusion for central nervous system neoplasms. Neurology 16, 680–692.
Rubin, R. C., Larson, R., Rall, D. P., 1966: 8-Azaguanine (NSC-749). I. Preclinical toxicity studies and a preliminary report on intrathecal perfusion therapy for patients. Cancer Chemother. Rep. 50,283–286.
Rubin, R., Owens, E., Rall, D., 1968: Transport of methotrexate by the choroid plexus. Cancer Res. 13,689–694.
Ruderman, N. B., Hall, T. C., 1965: Use of glucocorticoids in paliative treatment of metastatic brain tumors. Cancer 18, 298–306.
Serez, R. J., Campbell, R. J., Laws, E. R., Jr., 1977: Chemotherapeutic trials on human malignant astrocytomas in organ culture. J. Neurosurg. 46,320–327.
Sano, K., Hoshino, T., Nagai, M., 1968: Radiosensitization of brain tumor cells with a thymidine analogue (Bromouridine). J. Neurosurg. 28,530–538.
Sano, K., Hoshino, T., Nagai, M., Tsuchida, T., Sato, F., 1966: Studies on a radiosensitizer (5-Bromo-2Deoxyuridine) in the treatment of malignant brain tumours. Neurol. med. chir. 8,227–231.
Sartorelli, A. C., Johns, D. G., 1974: Antineoplastic and Immunosuppressive Agents. Berlin-Heidelberg-New York: Springer. 1974.
Schochet, S. S., Lampert, P. W., Earle, K. M., 1968: Neuronal changes induced by intrathecal vincristine sulfate. J. Neuropath. Exp. Neurol. 27, 654–658.
Schochet, S. S., Lampert, P. W., Earle, K. M., 1969: Oligodendroglial changes induced by intrathecal vincristine sulfate. Exp. Neurol. 1969, 23, 113–119.
Seil, F. J., Lampert, P. W., 1968: Neurofibrillary tangles induced by vincristine and vinblastine sulfate in central and peripheral neurons in vitro. Exp. Neurol. 21,219–230.
Shapiro, W. R., 1972: Effect of 1-(2-Chloriethyl)-3-cyclohexyl-1-nitrosourea CCNU (NSC-79037) in sesame oil administrated intramuscularly in the treatment of experimental brain tumors. Cancer Chemother. Rep. 56, 457–463.
Shapiro, W. R., Ausman, J. I., 1969: The Chemotherapy of Brain Tumors: A Clinical and Experimental Review. In: Recent Advances in Neurology, Chap. IV, 150–235. Edited by F. Plum. Philadelphia: F. A. Davis Company.
Shapiro, W. R., Ausman, J. I., Rall, D. P., 1970: Studies on the chemotherapy of experimental brain tumors. Evaluation of 1,3-Bis-(2-Chloriethyl)-1-introsourea, cyclophosphanide, mithramycine, and methotrexate. Cancer Res. 30,2401–2413.
Shapiro, W. R., 1971: Studies on the chemotherapy of experimental brain tumors: Evaluation of 1-(2-chloroethyl)-3-cyclotrexyl-1-introsourea, Vincristine and 5-Fluoroceracil. J. Nath. Cancer Inst. 46, 359–368.
Shapiro, W. R.,Chernik, N. L., Posner, J. B., 1973: Necrotizing encephalopathy following intra-ventricular instillation of methotrexate. Arch. Neurol. 28, 96–102.
Shapiro, W. R., 1974: The chemotherapy of intracerebral and subcutaneous murine gliomas. Arch. Neurol. 30, 222–226.
Shapiro, W. R., Young, D. F., Metha, B. M., 1975: Methotrexate: distribution in cerebrospinal fluid after intravenous ventricular and lumbar injections. N. Engl. J. Med. 293,161–166.
Smith, B., 1975: Brain damage after intrathecal metotrexate. J. Neurol. Neurosurg. Psyehiat. 38,810–815.
Stähelin, H., 1970: 4’-Demethyl-epipodopnyllotoxin thenylidene glucoside (VNI26) a podophyllum compound with a new mechanism of action. Europ. J. Cancer 6, 303–311.
Sugiura, K., 1967: Effect of 1,3-Bis-(2-chloroethyl)-1-introsourea (NSC 409962) and two related compounds on a spectrum of tumors. Cancer Res. 27, 179–189.
Sullivan, R. D., 1962: Continuous arterial infusion. Cancer chemotherapy. Surg. Clin. North Am. 1–32.
Tator, C. H., 1971: Uptake of tritiated methotrexate by an experimental glioma. Cancer Res. 31,1600–1605.
Tator, C. H., 1972: Chemotherapy of brain tumors. Uptake of tritiated methotrexate by a transplantable intracerebral ependymoblastome in mice. J. Neurosurg. 37, 1–8.
Tator, C. H., Wassenaar, W., Day, A., Wei Sum So, 1977: Therapy of an experimental glioma with systemic or intraneoplastic methotrexate or radiation. J. Neurosurg. 46, 175–184.
Tator, C. H., Wassenaar, W., 1977: Intraneoplastic injection of methotrexate for experimental brain-tumor chemotherapy. J. Neurosurg. 46, 165–174.
Tator, C. H., 1977: Intraneoplastic injection of CCNU for experimental brain tumor chemotherapy. Surg. Neurol. 7, 73–77.
Taveras, J. M., Thompson, H. G., Pool, J. L., 1962: Should we treat glioblastoma multiforme? A study of survival in 425 cases. Amer. J. Roentgenol. Radium Ther. Nucl. Med. 87,473–479.
Trabucchi, M., Cerri, C., Spano, P. F., Kumakuua, K., 1977: Guanosine 3’-5’-monophosphate in the CSF of neurological patients. Arch. Neurol. 34,12–13.
Ushio, Y., Hayakawa, T., Mogami, H., 1974: Uptake of triated methotrexate by mouse brain tumors after intravenous or intrathecal administration. J. Neurosurg. 40, 706–716.
Putten, L. M. van, Keizer, H. J., Mulder, J. H., 1976: Synchronization in tumour chemotherapy. Europ. J. Cancer 12,79–85.
Walker, M. D., Hurwitz, B. S., 1970: BCNU (1,3-Bis-(2-Chloroethyl)-1-Nitrosourea; NSC-409962) in the treatment of malignant brain tumor—a preliminary report. Cancer Chemother. Rep. 54,263–271.
Walker, M. D., Alexander, E., Jr., Hunt, W. E., Leventhal, L. M., Mahaley, M. S., Jr., Mealey, J., Norrell, H. A., Owens, G., Ransohoff, J., Wilson, C. B., Gehan, E. A., 1976: Evaluation of mithramycin in the treatment of anaplastic gliomas. J. Neurosurg. 44, 655–667.
Walker, M. D., Gehan, E. A., 1972: An evaluation of BCNU and irradiation alone and in combination for the treatment of malignant gliomas. Proc. Am. Ass. Cancer Res. 13, 67.
Walker, M. D., 1975: Chemotherapy: Adjuvant to surgery and radiation therapy. Seminars in Oncology 2,69–72.
Walker, M. D., Strike, T. A., 1976: An evaluation of methyl CCNU, BCNU and radiotherapy in treatment of malignant glioma. Proc. AACR, p. 163.
Wassenaar, W., Tator, C. H., Wei Sum So, 1973: The development of an intracerebral glioma model for brain tumor chemotherapy. J. Neurosurg. 39,293–301.
Weir, B., Band, P., Urtasun, R., Blain, G., McLean, D., Wilson, F., Mielke, B., Grace, M., 1976: Radiotherapy and CCNU in the treatment of supratentorial astrocytomas. J. Neurosurg. 45, 129–134.
Weiss, J. F., Cravioto, H., Bennet, K., Weiss, E. C., Ransohoff, J., 1976: Desmosterol in human and experimental brain tumors in tissue culture. Arch. Neurol. 33, 180–182.
Whiteside, J. A., Philips, F. S., Dargeon, H. W., Burcenal, J. H., 1958: Intrathecal amethosterin in neurological manifestations of leukemia. Arch. Intern. Med. 101,279–285.
Willson, N., Duffy, P. E., 1974: Morphologic changes associated with combined BCNU and radiation therapy in glioblastoma multiforme. Neurology 10, 465–471.
Wilson, C. B., Weilbaecher, R., McGarry, P., 1963: Characteristics of human brain tumors in tissue cultures and animal host. Surgical Forum 14, 430–431.
Wilson, C. B.,1964: Chemotherapy of brain tumors by continuous arterial infusion. Surgery 55, 640–653.
Wilson, C. B., Barker, M., 1965: Sensitivity of cell cultures of neural tumors to vinblastine sulfate (NSC-49842). Cancer Chemother. Rep. 44,9–13.
Wilson, C. B., Norrell, H., Jr., Barker, M., 1967: Intrathecal injection of methotrexate (NSC-740) in transplanted brain tumors. Cancer Chemother. Rep. 51, 1–5.
Wilson, C. B., Hoshino, T., 1969: Current trends in the chemotherapy of brain tumors with special reference to glioblastomas. J. Neurosurg. 31, 589–603.
Wilson, C. B., 1969: Current trends in the chemotherapy of brain tumors with special reference to glioblastomas. J. Neurosurg. 31,589–603.
Wilson, C. B., Boldrey, E. B., Enot, J. K., 1970: 1,3-Bis-(2-chloroethyl)-1-nitrosourea (N.S.C. 409962) in the treatment of brain tumours. Cancer Chemother. Rep. 54, 273–281.
Wilson, C. B., 1976: Chemotherapy of Brain Tumors. In: Advances in Neurology, Vol. 15, p. 361–368. Edited by Thompson, R. A., Green, J. R. Berlin-Heidelberg-New York: Springer.
Wilson, C. B., Gutin, P., Boldrey, E. B., Crafts, D., Levin, V. A., Enot, K. J., 1976: Single-agent chemotherapy of brain tumors. Arch. Neurol. 33, 739–744.
Wilson, C. B., Yorke, Ch., Jr., Levin, V. A., 1977: Intracranial Malignant Growth, Primary and Metastatic. In: Current Problems in Cancer. Editor Hickey, R. C., Year Book Medical publishers.
Wodinsky, I., Kensler, C. J., Rail, D. P., 1969: The induction and transplantation of brain tumors in neonate beagles. Abstracts Am. Assoc. Cancer Res., p. 99.
Woodhall, B., Hall, K., Mahaley, S., Jackson, J., 1959: Chemotherapy of brain cancer: experimental and clinical studies in localized hypothermic cerebral perfusion. Ann. Surg. 150,640–652.
Woodhall, B., 1960: Brain perfusion. Cancer Chemother. Rep. 10,11–13.
Woodhall, B., 1960: Results of perfusion¡ªneural tumors. Cancer Chemother. Rep. 10,93–98.
Woodhall, B., Pickrell, K. L., Georgiade, N. G., Mahaley, M. S., Jr., Dukes, H. T., 1960: Effect of hypothermia upon cancer chemotherapy. Application to external cancers of head and face structure. Ann. Surg. 151, 750–759.
Wright, R. L., Soloway, A. H., 1961: The efficacy of intracarotid injections. Neurology 11, 922–924.
Yohn, D. S., 1972: Oncogenic Viruses: Expectations and Applications in Neuropathology. Progress in Experimental Tumor Research, Vol. 17, p. 74–92. Editor: G. Bingham. Basel: S. Karger.
Young, H. F., Sakalas, R., Kaplan, A. M. Ph., 1976: Inhibition of cell-mediated immunity in patients with brain tumors. Surg. Neurol. 5, 19–22.
Zagler, R. F., Frisby, S. A., Oliverio, V. T., 1973: The effects of antibiotics and cancer chemotherapic agents on the cellular transport and antitumor activity of methotrexate in LIZIO mur nie leukemia. Cancer Res. 33, 1670–1676.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Springer-Verlag/Wien
About this chapter
Cite this chapter
Hildebrand, J., Brihaye, J. (1978). Chemotherapy of Brain Tumours. In: Krayenbühl, H., et al. Advances and Technical Standards in Neurosurgery. Advances and Technical Standards in Neurosurgery, vol 5. Springer, Vienna. https://doi.org/10.1007/978-3-7091-7062-5_2
Download citation
DOI: https://doi.org/10.1007/978-3-7091-7062-5_2
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-7064-9
Online ISBN: 978-3-7091-7062-5
eBook Packages: Springer Book Archive